支气管切除与肺癌查参与者的下肺功能有关
Anastasia K A L Kwee1, Bart Luijk2, Pim A de Jong3
1Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. A.k.a.l.kwee-2@umcutrecht.nl.
European radiology
|November 10, 2023
概括
支气管切除症在5.4%的肺癌查参与者中被发现,与增加的呼吸道症状有关. 在患有慢性阻塞性肺病 (COPD) 的个体中,它也与肺功能减弱和肺气的增加相关.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
背景情况:
- 支气管切除是胸部CT扫描中常见的一种偶然发现.
- 它在肺癌查人群中的临床意义尚不清楚.
- 了解这种关联对于准确的风险评估和患者管理至关重要.
研究的目的:
- 为了研究支气管和呼吸系统症状之间的关系.
- 评估与肺功能 (预测FEV1%,FEV1/FVC) 和肺的相关性.
- 为了区分这些关联在肺癌查参与者与或没有慢性阻塞性肺病 (COPD).
主要方法:
- 对来自NELSON肺癌查试验的3260名 (前) 吸烟者的分析.
- 经验丰富的胸部放射科医生对支气管切除症进行评分.
- 使用独立的t测试和多变量回归进行统计分析,以检查与肺功能,呼吸道症状和CT量化肺的关联.
主要成果:
- 支气管切除症在5.4%的参与者中被发现,COPD和非COPD组的患病率相似.
- 在COPD患者中,支气管切除与较低的FEV1%预测,较低的FEV1/FVC和增高的肺气显著相关.
- 支气管切除与COPD患者的咳,粘液过分和呼吸障碍,以及非COPD患者的咳,粘液过分和喘息相关.
结论:
- 支气管切除症发生在5.4%的肺癌查参与者中,与增加的呼吸道症状有关.
- 在患有COPD的参与者中,支气管切除与较差的肺功能和更多的肺气有关.
- 轻度支气管切除症的发现在肺癌查中通常具有有限的临床意义,除非同时存在轻度COPD.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Other Pulmonary Disorders
853
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
853
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217

